Source map — Experimental Lilly combination drug tops Zepbound in weight-loss trial
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| The Guardian | news | 60% |
| CNBC | news | 60% |
| Reuters | news | 60% |
| USA Today | news | 60% |
| Fierce Biotech | news | 60% |
| en.wikipedia.org | news | 50% |
| www.tradingkey.com | news | 50% |
| www.advisory.com | news | 50% |
| blavity.com | news | 50% |
| www.europesays.com | news | 50% |
| www.sowetan.co.za | news | 50% |
| www.cafepharma.com | news | 50% |
| www.kalios.health | news | 50% |
| ctv.veeva.com | news | 50% |
| madamenoire.com | news | 50% |
| dictionary.cambridge.org | news | 50% |
| www.vocabulary.com | news | 50% |
| www.dictionary.com | news | 50% |
| scienceinsights.org | news | 50% |
| www.devdiscourse.com | news | 50% |
| health.yahoo.com | news | 50% |
| www.fool.com | news | 50% |
| rocketnews.com | news | 50% |
| www.glp1authority.com | news | 50% |
| primexbt.com | news | 50% |
| www.zerohedge.com | news | 50% |
| stockanalysis.com | news | 50% |
| www.gurufocus.com | news | 50% |
| www.cnbc.com | news | 50% |
| finance.yahoo.com | news | 50% |
| www.medicaldaily.com | news | 50% |
| www.biopharmadive.com | news | 50% |
| stocktwits.com | news | 50% |
| arstechnica.com | news | 50% |
| pharmaphorum.com | news | 50% |